Jenny Bousfield is an analyst at RAND Europe with research experience in a range of health and social care topics. She has worked as a research assistant and Ph.D. candidate in several research institutes in the UK and Australia.
Her research has focused on healthy ageing and dementia, social inclusion and mental health. Earlier in her career she worked on several academic and commercial clinical trials on the development of medications for Alzheimer’s disease, including the novel use of existing drugs. Her research involvement in healthy ageing and dementia also included working on a large biomarkers study for the diagnosis of Alzheimer’s disease, and she has co-ordinated and recruited participants to several brain donation programmes. Most recently, Bousfield project-managed, collected and analysed data for a project developing and measure of social inclusion for individuals with mental health problems. This included multiple qualitative research methods, such as in-depth interviews, focus groups and stakeholders workshops.
Bousfield's Ph.D. was embedded in this larger project and explored gender and social inclusion in psychosis. This included a systematic review and the development of a rating scale for gender-sensitivity in social science research, and the exploration of sociodemographic factors involved in social exclusion in individuals with mental health problems. Through these experiences, she has gained extensive experience in recruiting to research through primary and secondary NHS services, as well as skills in quantitative, qualitative and mixed methods research.
Mezey, G., White, S., Harrison, I., Bousfield, J., Lloyd-Evans, B., Payne, S., & Killaspy, H., "Validity, reliability, acceptability and utility of the Social Inclusion Questionnaire User Experience (SInQUE); a clinical tool to facilitate social inclusion amongst people with severe mental health problems," Social Psychiatry and Psychiatric Epidemiology, 2020 (forthcoming)
McLachlan, E., Bousfield, J., Howard, R., & Reeves, S. , "Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease," International Journal of Geriatric Psychiatry, 33(2), 2020